A novel approach for simultaneous detection of structural and single-nucleotide variants based on a combination of chromosome conformation capture and exome sequencing

Maria Gridina,Timofey Lagunov,Polina Belokopytova,Nikita Torgunakov,Miroslav Nuriddinov,Artem Nurislamov,Lyudmila P Nazarenko,Anna A Kashevarova,Maria E Lopatkina,Elena O Belyaeva,Olga A Salyukova,Aleksandr D Cheremnykh,Natalia N. Suhanova,Marina E Minzhenkova,Zhanna G Markova,Nina A. Demina,Yana Stepanchuk,Anna Khabarova,Alexandra Yan,Emil Valeev,Galina Koksharova,Elena V Grigor’eva,Natalia Kokh,Tatiana Lukjanova,Yulia Maximova,Elizaveta Musatova,Elena Shabanova,Andrey Kechin,Evgeniy Khrapov,Uliana Boyarskih,Oxana Ryzhkova,Maria Suntsova,Alina Matrosova,Mikhail Karoli,Andrey Manakhov,Maxim Filipenko,Evgeny Rogaev,Nadezhda V Shilova,Igor N Lebedev,Veniamin Fishman
DOI: https://doi.org/10.1101/2024.01.26.577292
2024-01-29
Abstract:Effective molecular diagnosis of congenital diseases hinges on comprehensive genomic analysis, traditionally reliant on various methodologies specific to each variant type—whole exome or genome sequencing for single nucleotide variants (SNVs), array CGH for copy-number variants (CNVs), and microscopy for structural variants (SVs). We introduce a novel, integrative approach combining exome sequencing with chromosome conformation capture, termed Exo-C. This method enables the concurrent identification of SNVs in clinically relevant genes and SVs across the genome and allows analysis of heterozygous and mosaic carriers. Enhanced with targeted long-read sequencing, Exo-C evolves into a cost-efficient solution capable of resolving complex SVs at base-pair accuracy. Through several case studies, we demonstrate how Exo-C’s multifaceted application can effectively uncover diverse causative variants and elucidate disease mechanisms in patients with rare disorders.
Genomics
What problem does this paper attempt to address?